CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes A population-based study of 92 clinically recognised risk factors for heart failure: co-occurrence, prognosis and preventive potential Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation

Original Research2018 May 15;137(20):2101-2103.

JOURNAL:Circulation. Article Link

Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study

Januzzi JL Jr, Richards AM. Keywords: biomarkers; evidence-based medicine; guideline adherence; heart failure; natriuretic peptides

LINK


Please click on the "Article Link" to access the article.